Biological Basis for Cerebral Dysfunction in Schizophrenia in Contrast with Alzheimer’s Disease
Open Access
- 1 January 2014
- journal article
- review article
- Published by Frontiers Media SA in Frontiers in Psychiatry
- Vol. 4, 119
Abstract
Schizophrenia and Alzheimer’s disease are two disorders that, while conceptualized as pathophysiologically and clinically distinct, cause substantial cognitive and behavioral impairment worldwide, and target apparently similar — or nearby — circuitry in regions such as the temporal and frontal lobes. We review the salient differences and similarities from selected historical, nosological and putative mechanistic viewpoints, as a means to help both clinicians and researchers gain a better insight into these intriguing disorders, for which over a century of research and decades of translational development was needed to begin yielding treatments that are objectively effective, but still very far from entirely satisfactory. Ongoing comparison and “cross-pollination” among these approaches to disorders that produce similar deficits is likely to continue improving both our insight into the mechanisms at play, and the development of biotechnological approaches to tackle both conditions — and related disorders — more rapidly and efficaciously.Keywords
This publication has 74 references indexed in Scilit:
- Microglia activation mediates fibrillar amyloid-β toxicity in the aged primate cortexNeurobiology of Aging, 2011
- Exercise-Induced Cognitive Plasticity, Implications for Mild Cognitive Impairment and Alzheimer’s DiseaseFrontiers in Neurology, 2011
- Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly PeopleArchives of Neurology, 2010
- Neuron-glia synapses in the brainBrain Research Reviews, 2010
- Microglial C5aR (CD88) expression correlates with amyloid‐β deposition in murine models of Alzheimer’s diseaseJournal of Neurochemistry, 2010
- Integrative understanding of emergent brain properties, quantum brain hypotheses and connectome alterations in dementia are key challenges to conquer Alzheimer's diseaseFrontiers in Neurology, 2010
- Grand challenges in dementia 2010Frontiers in Neurology, 2010
- Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer’s diseaseActa Neuropathologica, 2009
- Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network AnalysisBiological Psychiatry, 2008
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991